WeirFoulds represents StageZero Life Sciences Ltd in its acquisition of the Health Clinics Business
On September 2, 2021, StageZero Life Sciences Ltd (“StageZero”) (TSX:SZLS) announced that it has completed its previously announced acquisition of the business of Health Clinics Limited (“Health Clinics”) through the […]
WeirFoulds represents PNG Copper Inc. in closing of $1.12 million private placement
On September 3, 2021, PNG Copper Inc. (“PNG Copper”) (CSE:PNGC) announced that it closed the third and final tranche of its private placement offering first announced in June 2021. In […]
Best Lawyers in Canada recognizes 50 WeirFoulds lawyers in 2022 edition including the new Best Lawyers Ones to Watch category
WeirFoulds congratulates 45 of our lawyers on being recognized in the 2022 edition of Best Lawyers in Canada and five of our senior associates on being recognized in the Best […]
WeirFoulds represents Orford Mining Corp. in a $1.92M private placement
On August 12, 2021, Orford Mining Corp. (Orford Mining) (TSX VENTURE: ORM) announced that it closed a non-brokered private placement raising gross proceeds of $1,920,000 from the sale of “flow-through” […]
WeirFoulds Represents Platform 9 in Closing of Qualifying Transaction
On May 19, 2021 Sol Cuisine Ltd (formerly Platform 9 Capital Corp.) (TSXV: PN.P) announced that it completed its previously announced “Qualifying Transaction” in accordance with the policies of the […]
WeirFoulds welcomes three new associates
WeirFoulds is pleased to welcome three new associates to the firm in the following practice areas: Dara W. Azari – Securities Law Dara is an associate in WeirFoulds’ Securities Practice […]
WeirFoulds represents Antibe Therapeutics in a $40M public offering
On February 24, 2020, Antibe Therapeutics Inc. (“Antibe”) (TSX: ATE) announced that it closed a bought deal public offering of 6,727,500 units (the “Units”) raising aggregate gross proceeds of $40,365,000. […]
WeirFoulds represents Psyence Group Inc. in listing on the CSE and subsidiary in $9.3M private placement
On January 26, 2021, Psyence Group Inc. (“Psyence”) (CSE: PSYG) announced that its common shares would begin trading on the Canadian Securities Exchange. Psyence listed after completing a reverse take-over […]
TSXV Introduces Changes to Capital Pool Company Program
Introduction On December 1, 2020, the TSX Venture Exchange (“TSXV” or the “Exchange“) announced changes to its Capital Pool Company (“CPC“) program, effective January 1, 2021.[1] Revisions to TSXV Policy […]
WeirFoulds represents StageZero Life Sciences Ltd. in $7.2M public offering
On December 4, 2020, StageZero Life Sciences Ltd. (“StageZero”) (TSX: SZLS) announced that it closed its previously announced public offering of 9,243,700 units (the “Units”) raising aggregate gross proceeds of […]
WeirFoulds represents Orford Mining Corp. in closing of $5.25 million financing
On October 19, 2020, Orford Mining Corp. (“Orford”, or the “Company”) (TSX: VENTURE ORM) announced the closing of its non-brokered private placement of: (i) flow-through units at an issue price of C$0.315 […]
WeirFoulds represents Hemlo Explorers Inc. in its closing of a fully-subscribed $3.5M non-brokered private placement
On August 25, 2020, Hemlo Explorers Inc. (“Hemlo”, or the “Company”) (TSXV: HMLO) announced the final closing of its non-brokered private placement offering of units (“Units”) for gross proceeds of […]
WeirFoulds represents Kontrol Energy Corp. in Acquisition of New Found Air
On August 4, 2020, Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol” or “Company”) acquired 100% of the issued and outstanding shares of New Found Air for consideration of $2.7 Million; paid as $1.55 […]
WeirFoulds represents Kontrol Energy Corp. in its closing of a private placement
On July 6, 2020, Kontrol Energy Corp. (“Kontrol”) (CSE: KNR, OTCQB: KNRLF, FSE:1K8) closed a private placement offering of units (“Units”). Kontrol raised $1,977,000 from issuing the Units, each of […]
WeirFoulds represents StageZero Life Sciences Ltd. in $4.6M public offering
On June 29, 2020, StageZero Life Sciences Ltd. (“StageZero”) (TSX: SZLS) completed a public offering of 66,176,100 units (the “Units”) at a price of $0.07 per Unit raising aggregate gross […]